Therefore, the topic of the usefulness of neurogranin in the diagnosis of neurodegenerative diseases and the possibility of its determination in CSF, as discussed in this article, raises both medical and legal issues [52]. This evidence concerns the gene NRGN and neurodegenerative disease.